FDA Renews Cardiovascular And Renal Drugs Advisory Committee Until August 27, 2028
XLV•FDA renews advisory committee
Aug. 20 (Reuters) - FDA:
- FDA: RENEWS CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE UNTIL AUGUST 27, 2028- Federal Register
XLV•XLV•
